Agilent Technologies has had a mixture of recent performances, with some instances of stock outperforming the market, but also instances of underperformance. Notable transactions include stock buys by Morningstar Investment Services and Tower Research Capital LLC, while Logan Capital Management and The Manufacturers Life Insurance Company reduced their holdings. New lab devices have been released, broadening the company's reach to lab researchers. Q2 earnings exceeded expectations, but there were also instances of the company's shares being sold. Concerning executive moves, Padraig Mcdonnell sold 1958 shares. The company's stock performance over the past five years would have yielded a 183% return had it been purchased then. The company's second-quarter earnings in 2024 missed the mark, which saw shares fall initially, but Q1 and Q4 in the same year beat estimates. The company cut its guidance due to slower market recoveries. The value of Agilent Technologies has been a point of discussion, particularly examining its standing in relation to fundamentals. CEO Michael McMullen sold 52,297 shares, it sat at a relative strength rating of 81, and its price target was lowered by several firms. Padraig McDonnell has been appointed as the new CEO.
Agilent Technologies A News Analytics from Mon, 30 Oct 2023 07:00:00 GMT to Sun, 09 Jun 2024 20:33:33 GMT -
Rating 3
- Innovation 0
- Information 7
- Rumor -6
